PembrolizumabInterstitial lung disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1778卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71173-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：370 / 370

相关论文

共 50 条

[21] PanitumumabInterstitial lung disease: case report
Reactions Weekly, 2013, 1451 (1) : 39 - 39
[22] Hydatid disease of the lung - With a case report
Evans, RG
LANCET, 1934, 1 : 1281 - 1283
[23] NivolumabInterstitial lung disease: case report
Reactions Weekly, 2019, 1749 (1) : 277 - 277
[24] PanitumumabInterstitial lung disease: case report
Reactions Weekly, 2020, 1787 (1) : 406 - 406
[25] NivolumabInterstitial lung disease: case report
Reactions Weekly, 2017, 1670 (1) : 210 - 210
[26] IpilimumabGranulomatous lung disease: case report
Reactions Weekly, 2017, 1681 (1) : 195 - 195
[27] CrizotinibInterstitial lung disease: case report
Reactions Weekly, 2014, 1516 (1) : 68 - 68
[28] ImatinibInterstitial lung disease: case report
Reactions Weekly, 2015, 1564 (1) : 104 - 104
[29] OsimertinibInterstitial lung disease: case report
Reactions Weekly, 2022, 1908 (1) : 452 - 452
[30] LenalidomideInterstitial lung disease: case report
Reactions Weekly, 2017, 1667 (1) : 193 - 193

← 1 2 3 4 5 →